NAVB   $0.0779  -2.99% Market Closed

Navidea Biopharmaceuticals Inc
Total Cash 3.86M
totalCashPerShare 0.039
EBITDA -10.13M
Total Debt 1.26M
quickRatio 0.488
currentRatio 0.564
Total Revenue 610.00
debtToEquity
Revenue/Share 0.0
ROA -1.07055
ROE
grossProfits
freeCashflow -7.77M
operatingCashflow -9.71M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -16787.91
profitMargins 0.0
enterpriseValue 1.34M
forwardPE
floatShares 64.07M
sharesOutstanding 100.08M
sharesShort 2.69M
sharesShortPriorMonth 534.87K
dateShortInterest
sharesPercentSharesOut 0.03%
heldPercentInsiders 0.36%
heldPercentInstitutions 0.00%
Short Ratio help_outline 0.52%
shortPercentOfFloat 0.04%
impliedSharesOutstanding
bookValue -0.033
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -8.81M
trailingEps -0.20%
forwardEps -0.16%
enterpriseToEbitda -0.13
lastDividendValue
lastDividendDate
currentQuarterEstimate 4Q 2021
institutionsCount 4
lastUpdated April 1, 2024, noon